These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16940761)

  • 21. Traditional Chinese medicine for modern treatment of Parkinson's disease.
    Han L; Xie YH; Wu R; Chen C; Zhang Y; Wang XP
    Chin J Integr Med; 2017 Aug; 23(8):635-640. PubMed ID: 28108911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of traditional Chinese medicine on animal model of Parkinson's disease].
    Wu B; Zhao S; Wang X; Dong Q; Zheng G
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2588-91. PubMed ID: 22256772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical analysis of Parkinson's disease treated by integration of traditional Chinese and western medicine.
    Li G
    J Tradit Chin Med; 1995 Sep; 15(3):163-9. PubMed ID: 8569250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease: new approaches to diagnosis and treatment.
    Yahr MD
    Acta Neurol Scand Suppl; 1993; 146():22-5. PubMed ID: 8333251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease. An overview of treatments and research.
    Tuite PJ
    Minn Med; 2001 May; 84(5):42-7. PubMed ID: 11398632
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic history of Parkinson's disease in Chinese medical treatises.
    Zheng GQ
    J Altern Complement Med; 2009 Nov; 15(11):1223-30. PubMed ID: 19922254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of selegiline as a neuroprotective agent in Parkinson's disease.
    Olanow CW; Mytilineou C; Tatton W
    Mov Disord; 1998; 13 Suppl 1():55-8. PubMed ID: 9613720
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of motor symptoms in Parkinson's disease].
    Morís-De la Tassa G; Arias-Rodríguez M
    Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 30. Understanding Parkinson's disease.
    Noble C
    Nurs Stand; 2007 May 2-8; 21(34):48-56; quiz 58. PubMed ID: 17518075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison table: drugs for Parkinson's disease.
    Med Lett Drugs Ther; 2017 Nov; 59(1534):e194-e196. PubMed ID: 29136402
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinson's disease, antiparkinson medicines, and driving.
    Álvarez FJ
    Expert Rev Neurother; 2016 Sep; 16(9):1023-32. PubMed ID: 27464001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacotherapy of Parkinson's disease].
    Ceballos-Baumann A
    MMW Fortschr Med; 2013 May; 155(8):49-51. PubMed ID: 24437138
    [No Abstract]   [Full Text] [Related]  

  • 37. Parkinson's disease. Second of two parts.
    Lang AE; Lozano AM
    N Engl J Med; 1998 Oct; 339(16):1130-43. PubMed ID: 9770561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson's disease in Taiwan.
    Chen KY; Wu MY; Yang PS; Chiang JH; Hsu CY; Chen CY; Yen HR
    J Ethnopharmacol; 2018 Nov; 226():168-175. PubMed ID: 30118835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.